Immunization: vital progress, unfinished agenda

Piot, Peter; Larson, Heidi J.; O’Brien, Katherine L.; N’kengasong, John; Ng, Edmond; Sow, Samba; Kampmann, Beate

doi:10.1038/s41586-019-1656-7

Cited by 209Vaccine Coverage and HesitancyImmune responses and vaccinationsBacterial Infections and Vaccines

Immunization: vital progress, unfinished agenda

Open access

Piot, Peter, Larson, Heidi J., O’Brien, Katherine L., N’kengasong, John, Ng, Edmond, Sow, Samba, Kampmann, Beate·2019·Nature

DOI 10.1038/s41586-019-1656-7

Open this paper in CoChat — free account Open PDF

Abstract

Vaccination against infectious diseases has changed the future of the human species, saving millions of lives every year, both children and adults, and providing major benefits to society as a whole. Here we show, however, that national and sub-national coverage of vaccination varies greatly and major unmet needs persist. Although scientific progress opens exciting perspectives in terms of new vaccines, the pathway from discovery to sustainable implementation can be long and difficult, from the financing, development and licensing to programme implementation and public acceptance. Immunization is one of the best investments in health and should remain a priority for research, industry, public health and society.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-019-1656-7

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Immune memory is the source of protective immunity from a subsequent infection.
“Immune memory is the source of protective immunity from a subsequent infection (Orenstein and Ahmed, 2017; Piot et al., 2019; Plotkin et al., 2018).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Piot et al., 2019

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32203-7 · Cited by 8,600 · see citing works
Ten Great Public Health Achievements—United States, 1900-1999
(1999) · JAMA · doi:10.1001/jama.281.16.1481 · Cited by 1,299 · see citing works
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
Restrepo, A. M. H., Camacho, A., Longini, I. M., Watson, C., Edmunds, W. J., Egger, M., Carroll, M. W., Dean, N. E., Diatta, I. D., Doumbia, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32621-6 · Cited by 1,112 · see citing works
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
Sridhar, S., Luedtke, A. R., Langevin, E., Zhu, M., Bonaparte, M. I., Machabert, T., Savarino, S. J., Zambrano, B., Moureau, A., Khromava, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800820 · Cited by 792 · see citing works
The basic reproduction number (R0) of measles: a systematic review
Guerra, F. M., Bolotin, S., Lim, G. H., Heffernan, J. M., Deeks, S. L., Li, Y., & Crowcroft, N. S. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30307-9 · Cited by 713 · see citing works
Translational research: crossing the valley of death
Butler, D. (2008) · Nature · doi:10.1038/453840a · Cited by 712 · see citing works
Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017
Lane, S., MacDonald, N. E., Marti, M., & Dumolard, L. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.03.063 · Cited by 530 · see citing works
Economic burden of seasonal influenza in the United States
Putri, W. C. W. S., Muscatello, D. J., Stockwell, M. S., & Newall, A. T. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.05.057 · Cited by 493 · see citing works
Simply put: Vaccination saves lives
Orenstein, W. A., & Ahmed, R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704507114 · Cited by 449 · see citing works
The complexity and cost of vaccine manufacturing – An overview
Plotkin, S. A., Robinson, J. M., Cunningham, G., Iqbal, R., & Larsen, S. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.003 · Cited by 437 · see citing works
Vaccines for the twenty-first century society
Rappuoli, R., Mandl, C. W., Black, S., & De Gregorio, E. (2011) · Nature Reviews Immunology · doi:10.1038/nri3085 · Cited by 388 · see citing works
Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011–20
Ozawa, S., Clark, S. E., Portnoy, A., Grewal, S. K., Brenzel, L., & Walker, D. G. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1086 · Cited by 378 · see citing works
An Introduction to Infectious Disease Modelling
Vynnycky, E., & White, R. L. (2010) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · Cited by 343 · see citing works
The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations
Karafillakis, E., & Larson, H. J. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.061 · Cited by 301 · see citing works
Self-citation
Tetanus
Yen, L. M., & Thwaites, L. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33131-3 · Cited by 269 · see citing works
Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009
Zhou, F., Shefer, A. M., Wenger, J. D., Messonnier, M. L., Wang, L. Y., Lopez, A. S., Moore, M. R., Murphy, T. V., Cortese, M. M., & Rodewald, L. E. (2014) · PEDIATRICS · doi:10.1542/peds.2013-0698 · Cited by 257 · see citing works
Vaccination Coverage Among Children Aged 19–35 Months — United States, 2017
Hill, H. A., Elam–Evans, L. D., Yankey, D., Singleton, J. A., & Kang, Y. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6740a4 · Cited by 251 · see citing works
Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects
Klugman, K. P., & BLACK, S. B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721095115 · Cited by 220 · see citing works
The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment
Smith, R., Keogh-Brown, M. R., Barnett, T., & Tait, J. (2009) · BMJ · doi:10.1136/bmj.b4571 · Cited by 200 · see citing works
Heterogeneity in Vaccine Immune Response: The Role of Immunogenetics and the Emerging Field of Vaccinomics
Poland, G. A., Ovsyannikova, I. G., Jacobson, R. M., & Smith, D. I. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100415 · Cited by 193 · see citing works
Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies
Hammitt, L. L., Akech, D., Morpeth, S. C., Karani, A., Kihuha, N., Nyongesa, S., Bwanaali, T., Mumbo, E., Kamau, T., Sharif, S. K., et al. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70224-4 · Cited by 189 · see citing works
Valuing vaccination
Bärnighausen, T., Bloom, D. E., Cafiero-Fonseca, E. T., & O’Brien, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400475111 · Cited by 188 · see citing works
Dynamic molecular changes during the first week of human life follow a robust developmental trajectory
Lee, A. H., Shannon, C. P., Amenyogbe, N., Bennike, T. B., Diray‐Arce, J., Idoko, O. T., Gill, E. E., Ben-Othman, R., Pomat, W. S., van Haren, S. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08794-x · Cited by 187 · see citing works
Self-citation
Measuring Coverage in MNCH: Design, Implementation, and Interpretation Challenges Associated with Tracking Vaccination Coverage Using Household Surveys
Cutts, F. T., Izurieta, H. S., & Rhoda, D. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001404 · Cited by 179 · see citing works
Antimicrobial resistance and the role of vaccines
Bloom, D. E., BLACK, S. B., SALISBURY, D. M., & Rappuoli, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717157115 · Cited by 176 · see citing works
Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness
Larson, H. J., Hartigan-Go, K. Y., & de Figueiredo, A. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1522468 · Cited by 173 · see citing works
Self-citation
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine
Wilder‐Smith, A., Hombach, J., Ferguson, N. M., Selgelid, M. J., O’Brien, K. L., Vannice, K., Barrett, A. D. T., Ferdinand, E., Flasche, S., Guzmán, M. G., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30494-8 · Cited by 169 · see citing works
Self-citation
Personalized vaccines: the emerging field of vaccinomics
Poland, G. A., Ovsyannikova, I. G., & Jacobson, R. M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.11.1659 · Cited by 164 · see citing works
Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000–2016: a spatial and temporal modelling study
Mosser, J. F., Gagne‐Maynard, W., Rao, P. C., Osgood-Zimmerman, A. E., Fullman, N., Graetz, N., Burstein, R., Updike, R. L., Liu, P. Y., Ray, S. E., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30226-0 · Cited by 163 · see citing works
Self-citation
Determinants of effective vaccine coverage in low and middle-income countries: a systematic review and interpretive synthesis
Phillips, D. E., Dieleman, J. L., Lim, S. S., & Shearer, J. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2626-0 · Cited by 162 · see citing works
Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations
Lam, E., McCarthy, A., & Brennan, M. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1096457 · Cited by 153 · see citing works
Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges
Aaby, P., Kollmann, T. R., & Benn, C. S. (2014) · Nature Immunology · doi:10.1038/ni.2961 · Cited by 141 · see citing works
Cost-effectiveness of adult vaccinations: A systematic review
Leidner, A. J., Murthy, N. C., Chesson, H. W., Biggerstaff, M., Stoecker, C., Harris, A. M., Acosta, A. M., Dooling, K. L., & Bridges, C. B. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.11.056 · Cited by 131 · see citing works
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials
Clark, A. D., van Zandvoort, K., Flasche, S., Sanderson, C. F. B., Bines, J. E., Tate, J. E., Parashar, U. D., & Jit, M. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30126-4 · Cited by 128 · see citing works
Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR
Sevilla, J. P., Bloom, D. E., Cadarette, D., Jit, M., & Lipsitch, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717161115 · Cited by 127 · see citing works
The broader economic impact of vaccination: reviewing and appraising the strength of evidence
Jit, M., Hutubessy, R., Png, M. E., Sundaram, N., Audimulam, J., Salim, S., & Yoong, J. (2015) · BMC Medicine · doi:10.1186/s12916-015-0446-9 · Cited by 119 · see citing works
Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2018*
Kim, D. K., Riley, L. E., & Hunter, P. H. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3439 · Cited by 114 · see citing works
What Is Wrong with Pertussis Vaccine Immunity?Preprint
Burdin, N., Handy, L., & Plotkin, S. A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029454 · Cited by 110 · see citing works
Establishing Efficacy of Human Products Using Animals
Snoy, P. (2010) · Veterinary Pathology · doi:10.1177/0300985810372506 · Cited by 109 · see citing works
Vaccines and global health: In search of a sustainable model for vaccine development and delivery
Rappuoli, R., BLACK, S. B., & Bloom, D. E. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw2888 · Cited by 105 · see citing works
The public health value of vaccines beyond efficacy: methods, measures and outcomes
Wilder‐Smith, A., Longini, I. M., ZUBER, P. L. F., Bärnighausen, T., Edmunds, W. J., Dean, N. E., Spicher, V. M., Benissa, M.-R., & Gessner, B. D. (2017) · BMC Medicine · doi:10.1186/s12916-017-0911-8 · Cited by 105 · see citing works
Safety of AS03-adjuvanted influenza vaccines: A review of the evidence
Cohet, C., der Most, R. G. V., Bauchau, V., Bekkat-Berkani, R., Doherty, T. M., Schuind, A., Silva, F. T. D., Rappuoli, R., Garçon, N., & Innis, B. L. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.048 · Cited by 102 · see citing works
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries
Kobayashi, M., Vekemans, J., Baker, C. J., Ratner, A. J., Doaré, K. L., & Schrag, S. J. (2016) · F1000Research · doi:10.12688/f1000research.9363.1 · Cited by 88 · see citing works
Challenges in adult vaccination
de Gomensoro, E., Giudice, G. D., & Doherty, T. M. (2018) · Annals of Medicine · doi:10.1080/07853890.2017.1417632 · Cited by 85 · see citing works
The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries
Chang, A. Y., Riumalló‐Herl, C., Perales, N. A., Clark, S. E., Clark, A. D., Constenla, D. O., Garske, T., Jackson, M. L., Jean, K., Jit, M., et al. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.0861 · Cited by 84 · see citing works
Meeting the Challenges of Immunizing Adults
Bridges, C. B., Hurley, L. P., Williams, W. W., Ramakrishnan, A., Dean, A. K., & Groom, A. V. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.08.014 · Cited by 76 · see citing works
America and Europe’s new normal: the return of vaccine-preventable diseases
Hotez, P. J. (2019) · Pediatric Research · doi:10.1038/s41390-019-0354-3 · Cited by 74 · see citing works
Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara–Vectored Ebola Vaccines at 1 Year
Winslow, R., Milligan, I. D., Voysey, M., Lühn, K., Shukarev, G., Douoguih, M., & Snape, M. D. (2017) · JAMA · doi:10.1001/jama.2016.20644 · Cited by 72 · see citing works
A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study
Westphal, D. W., Eastwood, A., Levy, A., Davies, J., Huppatz, C., Gilles, M. T., Lyttle, H., Williams, S. A., & Dowse, G. K. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30498-5 · Cited by 63 · see citing works
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2016
Kim, D.-K., Bridges, C. B., & Harriman, K. H. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13877 · Cited by 62 · see citing works
Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report
Fields, V., Safi, H., Waters, C., Dillaha, J. A., Capelle, L., Riklon, S., Wheeler, J. G., & Haselow, D. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30607-8 · Cited by 57 · see citing works
Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2017*
Kim, D. K., Riley, L. E., Harriman, K. H., Hunter, P. R., & Bridges, C. B. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2936 · Cited by 56 · see citing works
Gavi’s Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs
Kallenberg, J., Mok, W., Newman, R. D., Nguyen, A., Ryckman, T. S., Saxenian, H., & Wilson, P. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1079 · Cited by 54 · see citing works
Vaccination in the elderly
Derhovanessian, E., & Pawelec, G. (2012) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2011.00283.x · Cited by 51 · see citing works
Measles resurgence in the USA: how international travel compounds vaccine resistance
Sarkar, S., Zlojutro, A., Khan, K. Z., & Gardner, L. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30231-2 · Cited by 50 · see citing works
Searching for the human genetic factors standing in the way of universally effective vaccines
Mentzer, A. J., O’Connor, D., Pollard, A. J., & Hill, A. V. S. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0341 · Cited by 49 · see citing works
Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study
Riumalló‐Herl, C., Chang, A. Y., Clark, S. E., Constenla, D. O., Clark, A. D., Brenzel, L., & Verguet, S. (2018) · BMJ Global Health · doi:10.1136/bmjgh-2017-000613 · Cited by 44 · see citing works
Meeting the Challenges of Immunizing Adults
Bridges, C. B., Hurley, L. P., Williams, W. W., Ramakrishnan, A., Dean, A. K., & Groom, A. V. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.054 · Cited by 42 · see citing works
Biological challenges to effective vaccines in the developing world
Grassly, N. C., Kang, G., & Kampmann, B. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0138 · Cited by 35 · see citing works
Self-citation
What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
Brenzel, L. (2015) · Vaccine · doi:10.1016/j.vaccine.2014.12.076 · Cited by 35 · see citing works
Vaccine candidates for poor nations are going to waste
Kaslow, D. C., BLACK, S. B., Bloom, D. E., Datla, M., SALISBURY, D. M., & Rappuoli, R. (2018) · Nature · doi:10.1038/d41586-018-07758-3 · Cited by 35 · see citing works
A Short History of Vaccination
Plotkin, S. L., & Plotkin, S. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00001-8 · Cited by 32 · see citing works
Comparison of three rapid household survey sampling methods for vaccination coverage assessment in a peri-urban setting in Pakistan
Gong, W., Shah, M. T., Firdous, S., Jarrett, B. A., Moulton, L. H., Moss, W. J., Hayford, K. T., O’Brien, K. L., & Chandir, S. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy263 · Cited by 27 · see citing works
Self-citation
Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study
Chan, J., Nguyen, C. D., Lai, J., Dunne, E. M., Andrews, R. M., Blyth, C. C., Datta, S. S., Fox, K., Ford, R. L., Hinds, J., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021512 · Cited by 21 · see citing works
Prospects for preventing infant invasive GBS disease through maternal vaccination
Madhi, S. A., & Dangor, Z. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.02.025 · Cited by 20 · see citing works
Barriers to typhoid fever vaccine access in endemic countries
Khan, M. I., Franco‐Paredes, C., Sahastrabuddhe, S., Ochiai, R. L., Mogasale, V., & Gessner, B. D. (2017) · Research and Reports in Tropical Medicine · doi:10.2147/rrtm.s97309 · Cited by 19 · see citing works
Measles, war, and health-care reforms in Ukraine
Lancet, T. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31984-6 · Cited by 18 · see citing works
Vaccination lags behind in middle-income countries
Berkley, S. (2019) · Nature · doi:10.1038/d41586-019-01494-y · Cited by 17 · see citing works
Vaccines for the prevention of meningococcal capsular group B disease: What have we recently learned?
Findlow, J. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1091131 · Cited by 15 · see citing works
The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs
Muñoz, F. M., Damme, P. V., Dinleyici, E. Ç., Clarke, E., Kampmann, B., Heath, P. T., Levy, O., Leuridan, E. E., Cutland, C., Meulen, A. S.-T., et al. (2018) · mSphere · doi:10.1128/msphere.00221-18 · Cited by 13 · see citing works
Self-citation
Early Life HIV-1 Immunization: Providing a Window for Protection Before Sexual Debut
Permar, S. R., Levy, O., Kollman, T. R., Singh, A., & Paris, K. D. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0018 · Cited by 6 · see citing works
Ensuring access to medicines: How to stimulate innovation to meet patients’ needs?
Пантели, Д., Edwards, S., Richardson, E., Palm, W., & Mossialos, E. A. (2018) · Europe PMC (PubMed Central) · Cited by 4 · see citing works

Flagged first, then by citations

Sorted by citations

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656 · see citing works
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860 · see citing works
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790 · see citing works
“The vast majority of licensed human vaccines work on the basis of protective antibody responses, with neutralizing antibodies being the most common mechanism of action (Piot et al., 2019; Plotkin, 2010; Plotkin et al., 2018).”
The Vaccine-Hesitant Moment
Larson, H. J., Gakidou, E. E., & Murray, C. J. L. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2106441 · Cited by 516 · see citing works
Self-citation
Vaccine confidence in the time of COVID-19
Harrison, E. A., & Wu, J. W. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00634-3 · Cited by 477 · see citing works
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
Abbas, K., Procter, S. R., van Zandvoort, K., Clark, A. D., Funk, S., Mengistu, T., Hogan, D. R., Dansereau, E. A., Jit, M., Flasche, S., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30308-9 · Cited by 362 · see citing works
Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo
Kato, Y., Abbott, R. K., Freeman, B. L., Haupt, S., Gröschel, B., Silva, M., Menis, S., Irvine, D. J., Schief, W. R., & Crotty, S. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.001 · Cited by 267 · see citing works
Bcl6-Mediated Transcriptional Regulation of Follicular Helper T cells (TFH)
Choi, J., & Crotty, S. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.02.002 · Cited by 190 · see citing works
Control and prevention of infectious diseases from a One Health perspective
Ellwanger, J. H., da Veiga, A. B. G., Kaminski, V. D. L., Valverde-Villegas, J. M., de Freitas, A. W. Q., & Chies, J. A. B. (2021) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0256 · Cited by 183 · see citing works
The Changing Acceptance of COVID-19 Vaccination in Different Epidemic Phases in China: A Longitudinal Study
Wang, J., Lu, X., Lai, X., Lyu, Y., Zhang, H., Fenghuang, Y., Jing, R., Li, L., Yu, W., & Fang, H. (2021) · Vaccines · doi:10.3390/vaccines9030191 · Cited by 150 · see citing works
Immunological memory to SARS-CoV-2 assessed for up to eight months after infectionPreprint
Dan, J., Mateus, J., Kato, Y., Hastie, K., Yu, E., Faliti, C. E., Grifoni, A., Ramirez, S., Haupt, S., Frazier, A., et al. (2020) · bioRxiv · doi:10.1101/2020.11.15.383323 · Cited by 147 · see citing works
Mapping routine measles vaccination in low- and middle-income countries
Collaborators, L. B. O. D. V. C., Sbarra, A. N., Rolfe, S., Nguyen, J. Q., Earl, L., Galles, N. C., Marks, A., Abbas, K. M., Abbasi-Kangevari, M., Abbastabar, H., et al. (2021) · Nature · doi:10.1038/s41586-020-03043-4 · Cited by 125 · see citing works
Self-citation
Improving vaccination uptake among adolescents
Abdullahi, L. H., Kagina, B. M. N., Ndze, V. N., Hussey, G. D., & Wiysonge, C. S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011895.pub2 · Cited by 126 · see citing works
Factors in B cell competition and immunodominance
Abbott, R. K., & Crotty, S. (2020) · Immunological Reviews · doi:10.1111/imr.12861 · Cited by 107 · see citing works
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2020) · eScholarship (California Digital Library) · Cited by 121 · see citing works
Mapping routine measles vaccination in low- and middle-income countries.
Local Burden of Disease Vaccine Coverage, C. (2021) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · doi:10.48350/151131 · Cited by 75 · see citing works
B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models
Huang, D., Abbott, R. K., Havenar‐Daughton, C., Skog, P. D., Al-Kolla, R., Gröschel, B., Blane, T. R., Menis, S., Tran, J. T., Thinnes, T. C., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004489117 · Cited by 68 · see citing works
Coverage and Equity of Childhood Vaccines in China
Zhang, H., Lai, X., Mak, J., Sriudomporn, S., Zhang, H., Fang, H., & Patenaude, B. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.46005 · Cited by 71 · see citing works
The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making
Hutubessy, R. C. W., Lauer, J. A., Giersing, B. K., Sim, S. Y., Jit, M., Kaslow, D. C., & Botwright, S. (2023) · BMC Medicine · doi:10.1186/s12916-023-02929-0 · Cited by 68 · see citing works
Supramolecular Self-Assembled Peptide-Based Vaccines: Current State and Future Perspectives
Abdullah, T., Bhatt, K., Eggermont, L. J., O'Hare, N. R., Memić, A., & Bencherif, S. A. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.598160 · Cited by 65 · see citing works
Cancer vaccines: platforms and current progress
Lei, W., Zhou, K., Lei, Y., Qiu, L., & Zhu, H. (2025) · Molecular Biomedicine · doi:10.1186/s43556-024-00241-8 · Cited by 62 · see citing works
Vaccines and the social amplification of risk
Larson, H. J., Lin, L. K., & Goble, R. L. (2022) · Risk Analysis · doi:10.1111/risa.13942 · Cited by 62 · see citing works
Self-citation
Trends of the Global, Regional, and National Incidence of Measles, Vaccine Coverage, and Risk Factors in 204 Countries From 1990 to 2019
Wang, R.-T., Jing, W.-Z., Liu, M., & Liu, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.798031 · Cited by 65 · see citing works
Graphene-based nanomaterials as antimicrobial surface coatings: A parallel approach to restrain the expansion of COVID-19
Ayub, M. A., Othman, M. H. D., Khan, I. U., Yusop, M. Z. M., & Kurniawan, T. A. (2021) · Surfaces and Interfaces · doi:10.1016/j.surfin.2021.101460 · Cited by 53 · see citing works
Institutional mistrust and child vaccination coverage in Africa
Stoop, N., Hirvonen, K., & Maystadt, J.-F. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-004595 · Cited by 50 · see citing works
Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria
Williams, S. V., Akande, T. M., & Abbas, K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297326 · Cited by 65 · see citing works
Targeted Vaccine Allocation Could Increase the COVID-19 Vaccine Benefits Amidst Its Lack of Availability: A Mathematical Modeling Study in Indonesia
Fuady, A., Nuraini, N., Sukandar, K. K., & Lestari, B. W. (2021) · Vaccines · doi:10.3390/vaccines9050462 · Cited by 44 · see citing works
Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
Tulaeva, I., Kratzer, B., Campana, R., Curin, M., van Hage, M., Васильевна, К. А., Riabova, K. A., Karaulov, A. V., Khaitov, M. R., Pickl, W. F., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01368 · Cited by 40 · see citing works
Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study
Adeyanju, G. C., Sprengholz, P., & Betsch, C. (2022) · npj Vaccines · doi:10.1038/s41541-022-00489-7 · Cited by 38 · see citing works
Aluminum Nanoparticles Acting as a Pulmonary Vaccine Adjuvant-Delivery System (VADS) Able to Safely Elicit Robust Systemic and Mucosal Immunity
Wang, N., Wei, C., Zhang, Z., Liu, T., & Wang, T. (2020) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-020-01572-z · Cited by 37 · see citing works
Childhood vaccination uptake and associated factors among children 12–23 months in rural settings of the Gambia: a community-based cross-sectional study
Touray, E. S., Barrow, A., Kinteh, B., Badjie, M., Nget, M., Touray, J., Kinteh, S. L. S., Jatta, S. P., & Ceesay, L. (2021) · BMC Public Health · doi:10.1186/s12889-021-11810-9 · Cited by 37 · see citing works
Trained immunity and host‐pathogen interactions
Peignier, A., & Parker, D. (2020) · Cellular Microbiology · doi:10.1111/cmi.13261 · Cited by 36 · see citing works
Impact of immunization programs on 11 childhood vaccine-preventable diseases in China: 1950–2018
Pan, J., Wang, Y., Cao, L., Wang, Y., Zhao, Q., Tang, S., Gong, W., Guo, L., Liu, Z., Wen, Z., et al. (2021) · The Innovation · doi:10.1016/j.xinn.2021.100113 · Cited by 36 · see citing works
The role of non–COVID-specific and COVID-specific factors in predicting a shift in willingness to vaccinate: A panel study
Jamieson, K. H., Romer, D., Jamieson, P. E., Winneg, K. M., & Josh Pasek, B. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112266118 · Cited by 36 · see citing works
2020 update on human coronaviruses: One health, one world
Zhao, X., Ding, Y., Du, J., & Fan, Y. (2020) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2020.100043 · Cited by 33 · see citing works
Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference
Soni, D., van Haren, S. D., Idoko, O. T., Evans, J. T., Diray‐Arce, J., Dowling, D. J., & Levy, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590373 · Cited by 32 · see citing works
T FH cells depend on Tcf1-intrinsic HDAC activity to suppress CTLA4 and guard B-cell help function
Li, F., Zhao, X., Zhang, Y., Shao, P., Ma, X., Paradee, W. J., Liu, C., Wang, J., & Xue, H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014562118 · Cited by 32 · see citing works
Critical success factors for routine immunization performance: A case study of Zambia 2000 to 2018
Micek, K., Hester, K. A., Chanda, C., Darwar, R., Dounebaine, B., Ellis, A. S., Keskinocak, P., Leslie, A., Manyando, M., Manyando, M. S., et al. (2022) · Vaccine X · doi:10.1016/j.jvacx.2022.100166 · Cited by 32 · see citing works
Immunostimulatory DNA Nanogel Enables Effective Lymphatic Drainage and High Vaccine Efficacy
Sun, J., Pan, M., Liu, F., Yu, W., Wang, W., Mo, F., Yu, S., Zhou, Y., & Liu, X. (2020) · ACS Materials Letters · doi:10.1021/acsmaterialslett.0c00445 · Cited by 31 · see citing works
Communicating COVID-19 vaccines: lessons from the dengue vaccine controversy in the Philippines
Lasco, G., & Yu, V. G. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-005422 · Cited by 31 · see citing works
The overlapping burden of the three leading causes of disability and death in sub-Saharan African children
Reiner, R. C., Collaborators, L. T. B., Welgan, C. A., Troeger, C., Baumann, M. M., Weiss, D. J., Deshpande, A., Blacker, B. F., Miller-Petrie, M. K., Earl, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34240-6 · Cited by 31 · see citing works
The Immune Signatures data resource, a compendium of systems vaccinology datasets
Diray‐Arce, J., Miller, H. E. R., Henrich, E., Gerritsen, B., Mulè, M. P., Fourati, S., Gygi, J. P., Hagan, T., Tomalin, L. E., Rychkov, D., et al. (2022) · Scientific Data · doi:10.1038/s41597-022-01714-7 · Cited by 31 · see citing works
Cooling with the sun: Empowering off-grid communities in developing countries with solar-powered cold storage systems
Garcia, E. D. S., Quaresma, N., Aemro, Y. B., Coimbra, A. P., & de Almeida, A. T. (2024) · Energy Research & Social Science · doi:10.1016/j.erss.2024.103686 · Cited by 28 · see citing works
Characterization of memory T cell subsets and common γ−chain cytokines in convalescent COVID-19 individuals
Rajamanickam, A., Kumar, N. P., Pandiaraj, A. N., Selvaraj, N., Munisankar, S., Renji, R. M., Venkataramani, V., Murhekar, M., Thangaraj, J. W. V., Muthusamy, S. K., et al. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.5cova0721-392rr · Cited by 27 · see citing works
Critical success factors for high routine immunization performance: A case study of Senegal
Sakas, Z., Hester, K. A., Rodriguez, K., Diatta, S. A., Ellis, A. S., Gueye, D. M., Mapatano, D., Mboup, S., Ogutu, E. A., Yang, C., et al. (2023) · Vaccine X · doi:10.1016/j.jvacx.2023.100296 · Cited by 28 · see citing works
Cold Chain Maintenance and Vaccine Stock Management Practices at Public Health Centers Providing Child Immunization Services in Jimma Zone, Oromia Regional State, Ethiopia: Multi-Centered, Mixed Method Approach
Feyisa, D. (2021) · Pediatric Health Medicine and Therapeutics · doi:10.2147/phmt.s312039 · Cited by 26 · see citing works
Multiple antigen presenting system (MAPS): state of the art and potential applications
Malley, R., Lu, Y., Sebastian, S., Zhang, F., & Willer, D. O. (2024) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2299384 · Cited by 25 · see citing works
Advancing Immunization in Africa: Overcoming Challenges to Achieve the 2030 Global Immunization Targets
Okesanya, O. J., Olatunji, G. D., Olaleke, N. O., Mercy, M., Ilesanmi, A., Kayode, H., Manirambona, E., Ahmed, M. M., Ukoaka, B. M., & Lucero‐Prisno, D. E. (2024) · Adolescent Health Medicine and Therapeutics · doi:10.2147/ahmt.s494099 · Cited by 24 · see citing works
An evaluation of the clinical features of measles virus infection for diagnosis in children within a limited resources setting
Husada, D., Kusdwijono, Puspitasari, D., Kartina, L., Basuki, P. S., & Ismoedijanto (2020) · BMC Pediatrics · doi:10.1186/s12887-020-1908-6 · Cited by 23 · see citing works
Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy
Masjedi, M., Montahaei, T., Sharafi, Z., & Jalali, A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103184 · Cited by 23 · see citing works
Critical success factors for high routine immunization performance: A case study of Nepal
Hester, K. A., Sakas, Z., Ellis, A. S., Bose, A. S., Darwar, R., Gautam, J. S., Jaishwal, C., James, H., Keskinocak, P., Nazzal, D., et al. (2022) · Vaccine X · doi:10.1016/j.jvacx.2022.100214 · Cited by 22 · see citing works
A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant
Rossi, I., Spagnoli, G., Buttini, F., Sonvico, F., Stellari, F. F., Cavazzini, D., Chen, Q., Müller, M., Bolchi, A., Ottonello, S., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.002 · Cited by 21 · see citing works
Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people
Vitallé, J., Pérez‐Gómez, A., Ostos, F. J., Gasca‐Capote, C., Jiménez‐León, M. R., Bachiller, S., Rivas‐Jeremías, I., Silva-Sánchez, M. D. M., Ruiz-Mateos, A. M., Martín-Sánchez, M. Á., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.161045 · Cited by 21 · see citing works
Malaria vaccination in Africa: A mini-review of challenges and opportunities
Olawade, D. B., Wada, O. Z., Ezeagu, C. N., Aderinto, N., BALOGUN, M. A., Asaolu, F. T., & David-Olawade, A. C. (2024) · Medicine · doi:10.1097/md.0000000000038565 · Cited by 20 · see citing works
Vaccines as remedy for antimicrobial resistance and emerging infections
Troisi, M., Andreano, E., Sala, C., Kabanova, A., & Rappuoli, R. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.09.003 · Cited by 20 · see citing works
Immune response induced by novel coronavirus infection
Sun, Y., Zou, Y., Wang, H., Cui, G.-Y., Yu, Z., & Ren, Z.-G. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.988604 · Cited by 14 · see citing works
Enablers and barriers of maternal and neonatal immunization programs in Latin America
Álvarez, A., Vilajeliu, A., Magariños, M., Jaúregui, B., Barrera, L. S. G., Whittembury, Á., Cain, E., Garcia, O., Montesanos, R., & Matus, C. R. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.07.051 · Cited by 20 · see citing works
Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage
Unwin, H. J. T., Mwandigha, L., Winskill, P., Ghani, A. C., & Hogan, A. B. (2021) · Malaria Journal · doi:10.1186/s12936-021-03966-x · Cited by 19 · see citing works
Validity of maternal recall for estimating childhood vaccination coverage – Evidence from Nigeria
Eze, P., Aniebo, C. L., Agu, U. J., Agu, S. A., & Acharya, Y. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.11.060 · Cited by 19 · see citing works
Vaccination decision-making among mothers of children 0–12 months old in Nigeria: A qualitative study
Adeyanju, G. C., & Betsch, C. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2355709 · Cited by 19 · see citing works
Understanding immune variation for improved translational medicine
Duffy, D. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.06.005 · Cited by 17 · see citing works
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case
Kochhar, S., Barreira, D., Beattie, P., Cavaleri, M., Cravioto, A., Frick, M. W., Ginsberg, A. M., Hudson, I., Kaslow, D. C., Kurtz, S. L., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2021.10.062 · Cited by 17 · see citing works
The impact of armed conflict on vaccination coverage: a systematic review of empirical evidence from 1985 to 2025
Headley, T. Y., Shay, C., & Tozan, Y. (2025) · Conflict and Health · doi:10.1186/s13031-025-00708-7 · Cited by 17 · see citing works
Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence
Udayachalerm, S., Renouard, M., Anothaisintawee, T., Thakkinstian, A., Veettil, S. K., & Chaiyakunapruk, N. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.2008195 · Cited by 16 · see citing works
Disruptions to childhood immunisation due to the COVID-19 pandemic
Abbas, K., & Mogasale, V. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01418-5 · Cited by 16 · see citing works
Manifesto on the Value of Adult Immunization: “We Know, We Intend, We Advocate”
Incalzi, R. A., Blasi, F., Conversano, M., Gabutti, G., Giuffrida, S., Maggi, S., Marano, C., Rossi, A., & Vicentini, M. (2021) · Vaccines · doi:10.3390/vaccines9111232 · Cited by 16 · see citing works
Acceptability of mobile-phone reminders for routine childhood vaccination appointments in Nigeria – a systematic review and meta-analysis
Eze, P., Agu, S. A., Agu, U. J., & Acharya, Y. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-07296-1 · Cited by 15 · see citing works
Nanotechnology of inhalable vaccines for enhancing mucosal immunity
Li, Q., Sun, Y., Gao, N., Ling, G., & Zhang, P. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01431-7 · Cited by 14 · see citing works
Bile Acids Impair Vaccine Response in Children With Biliary Atresia
Liu, J., Fei, Y., Zhou, T., Ji, H., Wu, J. Y., Gu, X., Luo, Y., Zhu, J., Feng, M., Wan, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642546 · Cited by 13 · see citing works
Microneedle-based two-step transdermal delivery of Langerhans cell-targeting immunoliposomes induces a Th1-biased immune response
Yu, Y., Wang, H., Guo, B., Wang, B., Wan, Z., Zhang, Y., Sun, L., & Yang, F. H. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.06.004 · Cited by 14 · see citing works
Diagnostic accuracy of dried blood spots for serology of vaccine-preventable diseases: a systematic review
Holroyd, T. A., Schiaffino, F., Chang, R. H., Wanyiri, J. W., Saldanha, I. J., Gross, M., Moss, W. J., & Hayford, K. T. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2013821 · Cited by 13 · see citing works
Study of Interactions between Antigens and Polymeric Adjuvants in Vaccines by Frontal Analysis Continuous Capillary Electrophoresis
Malburet, C., Leclercq, L., Cotte, J., Thiebaud, J., & Cottet, H. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00782 · Cited by 13 · see citing works
Characterization of National Immunization Programs in the Context of Public Health Emergencies: A Case Study of 13 Countries in the WHO Africa Region
Chepkurui, V., Amponsah‐Dacosta, E., Haddison, E. C., & Kagina, B. M. N. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.736532 · Cited by 12 · see citing works
Factors associated with recommendation behaviors of four non-National Immunization Program vaccines: a cross-sectional survey among public health workers in China
Lyu, Y., Lai, X., Ma, Y., & Fang, H. (2023) · Infectious Diseases of Poverty · doi:10.1186/s40249-023-01142-8 · Cited by 12 · see citing works
Effectiveness of mRNA and viral‐vector vaccines in epidemic period led by different SARS‐CoV‐2 variants: A systematic review and meta‐analysis
Zhang, J., Yang, W., Huang, F., & Zhang, K. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28623 · Cited by 11 · see citing works
Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy
Prosser, W., Sagar, K. S., Seidel, M., & Alva, S. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08616-9 · Cited by 11 · see citing works
Intestinal Helminth Infection Impairs Oral and Parenteral Vaccine Efficacy
Zhang, Y., Hardy, L. C., Kapita, C. M., Hall, J. A., Arbeeva, L. S., Campbell, E., Urban, J. F., Belkaid, Y., Nagler‐Anderson, C., & Iweala, O. I. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300084 · Cited by 11 · see citing works
Lessons for medical countermeasure development from unforeseen outbreaks
Mura, M., Trignol, A., Dault, E. L., & Tournier, J. (2025) · Emerging Microbes & Infections · doi:10.1080/22221751.2025.2471035 · Cited by 10 · see citing works
Understanding the continuous vaccination of the COVID-19 vaccine: an empirical study from China
Zhu, W., Zou, H., Song, Y., Ren, L., & Xu, Y. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.2013080 · Cited by 10 · see citing works
The Vaccine Training Barometer: Assessing healthcare providers’ confidence to answer vaccine-related questions and their training needs
Waele, A. D., Hendrickx, G., Valckx, S., Domı́nguez, Á., Toledo, D., Castilla, J., Tuells, J., & Damme, P. V. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.02.078 · Cited by 10 · see citing works
Bridging Gaps in Vaccine Access and Equity: A Middle Eastern Perspective
AL-Eitan, L. N., Almahdawi, D. L., Khiarah, R. A. A., & Alghamdi, M. A. (2025) · Vaccines · doi:10.3390/vaccines13080806 · Cited by 9 · see citing works
A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations
Dowling, D. J., & Levy, O. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac342 · Cited by 8 · see citing works
The Addis Declaration on Immunization: A binding reminder of the political support needed to achieve universal immunization in Africa
Mihigo, R., Okeibunor, J., Karmal, F., O’Malley, H., Godinho, N., Okero, L., Poy, A., Onyango, O., & Fitzgerald, N. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.06.073 · Cited by 9 · see citing works
Conformation-Stabilized Amorphous Nanocoating for Rational Design of Long-Term Thermostable Viral Vaccines
Zhang, Y., Hao, H., Lin, J., Ma, Z., Li, H., Nie, Z., Cui, Y., Guo, Z., Zhang, Y., Wang, X., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c12065 · Cited by 9 · see citing works
Memory T Cells Discrepancies in COVID-19 Patients
AlSaihati, H., Hussein, H. A. M., Thabet, A. A., Wardany, A. A., Mahmoud, S. Y., Farrag, E. S., Mohamed, T. I. A., Fathy, S. M., Elnosary, M. E., Sobhy, A., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11112737 · Cited by 11 · see citing works
Immunization of Rabbits with a QuadrivalentShigellaBioconjugate Vaccine Induces Functional Antibodies Reactive withShigellaIsolates from Kenya
Odundo, E. A., Weerts, H. P., Musila, L. A., Ogonda, L., Dreyer, A. M., Schneider, J., Carranza, P., & Kaminski, R. W. (2022) · mSphere · doi:10.1128/msphere.01020-21 · Cited by 9 · see citing works
Vaccine Coverage in Children Younger Than 1 Year of Age during Periods of High Epidemiological Risk: Are We Preparing for New Outbreaks?
Herdea, V., Ghionaru, R., Lungu, C. N., Leibovitz, E., & Diaconescu, S. (2022) · Children · doi:10.3390/children9091334 · Cited by 9 · see citing works
Induction of mucosal immunity against pathogens by using recombinant baculoviral vectors: Mechanisms, advantages, and limitations
Fragoso-Saavedra, M., & Vega‐López, M. A. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0320-488r · Cited by 9 · see citing works
Spatial distribution and determinants of measles vaccination dropout among under-five children in Ethiopia: A spatial and multilevel analysis of 2019 Ethiopian demographic and health survey
Zegeye, A. F., Mekonen, E. G., Tekeba, B., Alemu, T. G., Ali, M. S., Gonete, A. T., Kassie, A. T., Workneh, B. S., Tamir, T. T., & Wassie, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0305393 · Cited by 8 · see citing works
Concerns and challenges in clinics-guided nanovaccines design and applications
Gao, Y., Hua, S., Dong, X., Zhang, K., Zhang, X., & Yang, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.10.041 · Cited by 8 · see citing works
Simultaneous Immunization with Multiple Diverse Immunogens Alters Development of Antigen-Specific Antibody-Mediated Immunity
Pilewski, K. A., Kramer, K. J., & Georgiev, I. S. (2021) · Vaccines · doi:10.3390/vaccines9090964 · Cited by 8 · see citing works
A Practical Guide to Full Value of Vaccine Assessments
Trotter, C. L., Giersing, B. K., Lindstrand, A., Bar‐Zeev, N., Cernuschi, T., Franzel, L., Friede, M., Hombach, J., Jansen, M., Hasso-Agopsowicz, M., et al. (2024) · Vaccines · doi:10.3390/vaccines12020201 · Cited by 8 · see citing works
The equity road ahead for financing non-national immunization program vaccines in China: challenges and opportunities from a qualitative study
Jiang, M., Jiang, W., Yan, X., Ma, H., Zhou, S., & Ying, X. (2024) · International Journal for Equity in Health · doi:10.1186/s12939-024-02282-5 · Cited by 7 · see citing works
Childhood immunization coverage during the COVID-19 Pandemic in the Province of Siracusa, Italy
Contarino, F. M., Pietro, E. D., Bella, F., Randazzo, C., & Contrino, M. L. (2022) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2022.63.4.2587 · Cited by 7 · see citing works
Critical success factors for high routine immunisation performance: a qualitative analysis of interviews and focus groups from Nepal, Senegal, and Zambia
Sakas, Z., Hester, K. A., Ellis, A. S., Ogutu, E. A., Rodriguez, K., Bednarczyk, R. A., Dixit, S. M., Kilembe, W., Sarr, M., & Freeman, M. C. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-070541 · Cited by 7 · see citing works
Influenza Vaccine Hesitancy and Its Determinants Among Rheumatology Patients
Valerio, V., Hudson, M., Wang, M., Bernatsky, S., Hazel, E. M., Ward, B. J., & Colmegna, I. (2022) · ACR Open Rheumatology · doi:10.1002/acr2.11408 · Cited by 7 · see citing works
Parental preference for Haemophilus influenzae type b vaccination in Zhejiang Province, China: A discrete choice experiment
Wang, X., Feng, Y., Zhang, Q., Ye, L., Cao, M., Liu, P., Liu, S., Li, S., & Zhang, J. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.967693 · Cited by 7 · see citing works
Lipo-pam™ adjuvanted herpes zoster vaccine induces potent gE-specific cellular and humoral immune responses
Jeong, S., Ham, S.-J., Baek, S.-H., Jung, E.-J., Jo, H.-J., Cha, H., Lee, J. M., Ahn, B. C., Yum, J. S., & Chun, E. (2024) · npj Vaccines · doi:10.1038/s41541-024-00939-4 · Cited by 6 · see citing works
The Immune Signatures Data Resource: A compendium of systems vaccinology datasetsPreprint
Diray‐Arce, J., Miller, H. E. R., Henrich, E., Gerritsen, B., Mulè, M. P., Fourati, S., Gygi, J. P., Hagan, T., Tomalin, L. E., Rychkov, D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.05.465336 · Cited by 6 · see citing works
Mitigating dengue incidence through advanced Aedes larval surveillance and control: A successful experience from Pakistan
Abbas, S., Abbas, M., Alam, A., Hussain, N., Irshad, M., Khaliq, M., Han, X., Hafeez, F., Romano, D., & Chen, R. (2024) · Bulletin of Entomological Research · doi:10.1017/s0007485324000269 · Cited by 5 · see citing works

Authors: Piot, P., Larson, H. J., O’Brien, K. L., N’kengasong, J., Ng, E., Sow, S., & Kampmann, B.
Affiliations: London School of Hygiene & Tropical Medicine (GB)
University of Antwerp (BE)
World Health Organization (CH)
Centre Pour le Développement des Vaccins-Mali (ML)
ORCID: Larson, Heidi J.
O’Brien, Katherine L.
Ng, Edmond
Sow, Samba
Kampmann, Beate
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2019-11-06
Volume: 575
Issue: 7781
Pages: 119-129
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-019-1656-7
OpenAlex: W2985393490
Cited by: 206
References: 72
Citations by year: 2026: 21 · 2025: 23 · 2024: 28 · 2023: 21 · 2022: 45 · 2021: 39 · 2020: 29
FWCI: 6.17
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Bill and Melinda Gates Foundation
Pfizer
World Health Organization
Wellcome Trust
UK Research and Innovation
National Institute for Health and Care Research (SRF-2009-02-07)
European Commission
Medical Research Council (MR/R005990/1, MC_PC_17221, MR/R005990/2, MC_EX_MR/K011944/1, MC_EX_MR/P024270/1)
Topics: Social Sciences › Health › Vaccine Coverage and Hesitancy
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords: immunization, vaccination, vaccination coverage, vaccine development, vaccine implementation, vaccine safety, vaccine financing, vaccine licensure, vaccine hesitancy, infectious disease prevention, public health investment
MeSH terms: Drug Development, Animals, Humans, Mortality, Philippines, Social Change, Vaccination, Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Immunization: vital progress, unfinished agenda

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks